Table 3.

Distribution of cannabis use after diagnosis by patient characteristics (N=1120)

	Used cannabis		Did not use cannabis		Unadjusted		Adjusted
	N	(%)	N	(%)	OR	(95% CI)	OR	(95%CI)
All
	356		764
Age
≤ 45	79	(22)	87	(11)	2.59	(1.63–4.09)	2.16	(0.91–5.10)
46–64	160	(45)	315	(41)	1.37	(0.99–1.90)	1.44	(0.72–2.89)
≥ 65	117	(33)	362	(47)	Ref.	—	Ref.	—
Gender
Male	181	(51)	359	(47)	1.15	(0.85–1.54)	0.97	(0.58–1.60)
Female	173	(49)	404	(53)	Ref.	—	Ref.	—
Non-binary	2	(1)	1	(0)	—	—	—	—
Race
White	291	(82)	621	(81)	Ref.	—	Ref.	—
Asian/Asian American Pacific Islander	17	(5)	60	(8)	0.70	(0.37–1.34)	0.78	(0.37–1.68)
Black	25	(7)	45	(6)	1.24	(0.70–2.20)	1.25	(0.65–2.41)
Mixed or other	23	(6)	38	(5)	1.36	(0.66–2.80)	0.72	(0.34–1.52)
Hispanic
No	330	(93)	710	(93)	0.99	(0.54–1.79)	0.88	(0.41–1.88)
Yes	26	(7)	54	(7)	Ref.	—	Ref.	—
Income
<$50,000	49	(14)	123	(16)	0.85	(0.55–1.31)	1.31	(0.69–2.51)
$50,000-$99,000	100	(28)	202	(26)	0.92	(0.65–1.31)	1.07	(0.68–1.69)
≥$100,000	207	(58)	439	(57)	Ref.	—	Ref.	—
Insurance
Private Insurance	215	(60)	399	(52)	Ref.	—	Ref.	—
Medicare	103	(29)	291	(38)	0.67	(0.49–0.93)	0.86	(0.45–1.66)
Uninsured	17	(5)	32	(4)	0.91	(0.43–1.93)	0.82	(0.38–1.76)
Medicaid or state program	14	(4)	33	(4)	0.83	(0.38–1.84)	0.97	(0.33–2.79)
Other	7	(2)	9	(1)	1.35	(0.44–4.10)	1.33	(0.16–10.8)
Marital Status
Married/living as married	249	(70)	551	(72)	Ref.	—	Ref.	—
Divorced/separated	48	(13)	92	(12)	1.32	(0.84–2.05)	1.03	(0.60–1.77)
Single	49	(14)	67	(9)	1.51	(0.90–2.54)	0.69	(0.33–1.42)
Widowed	10	(3)	54	(7)	0.48	(0.22–1.04)	0.78	(0.32–1.92)
Employment status
Retired or disabled	144	(40)	361	(47)	0.76	(0.55–1.04)	1.09	(0.62–1.90)
Employed	158	(44)	326	(43)	Ref.	—	Ref.	—
Other	54	(15)	77	(10)	1.38	(0.85–2.23)	2.03	(1.10–3.73)
Highest level of education
< High school graduation	4	(1)	20	(3)	0.57	(0.16–2.06)	0.37	(0.09–1.52)
12 yrs or graduated high school	29	(8)	94	(12)	0.58	(0.33–1.00)	0.42	(0.17–1.04)
Post high school training / some college	52	(15)	162	(21)	0.66	(0.43–1.04)	0.55	(0.3–1.00)
College graduate	143	(40)	236	(31)	1.15	(0.81–1.64)	0.93	(0.61–1.41)
Postgraduate	128	(36)	252	(33)	Ref.	—	Ref.	—
Cancer site
Brain	24	(7)	42	(5)	2.04	(0.89–4.49)	0.96	(0.38–2.42)
Breast	46	(13)	129	(17)	1.01	(0.62–1.94)	0.77	(0.35–1.70)
Head and neck	41	(12)	90	(12)	1.24	(0.69–2.24)	1.15	(0.53–2.53)
Gynecological	39	(11)	94	(12)	1.26	(0.69–2.29)	1.20	(0.53–2.70)
Gastrointestinal	53	(15)	92	(12)	1.84	(1.04–3.25)	2.64	(1.27–5.50)
Lung	30	(8)	90	(12)	Ref.	—	Ref.	—
Lymphoma	44	(12)	74	(10)	1.71	(0.94–3.11)	1.55	(0.74–3.26)
Prostate	42	(12)	94	(12)	1.32	(0.73–2.37)	1.36	(0.64–2.86)
Testicular	17	(5)	12	(2)	4.34	(1.77–10.6)	2.28	(0.64–8.15)
Other	20	(6)	47	(6)	1.22	(0.57–2.61)	1.20	(0.50–2.89)
Cannabis use prior to diagnosis
Yes	172	(48)	39	(5)	16.5	(10.5–25.9)	19.1	(11.9–20.7)
No	184	(52)	725	(95)	Ref.	—	Ref.	—

Note: Proportions shown among respondents included in the multivariable complete case analysis (N=1120). Analyses were not performed for non-binary patients due to small sample size (N=3)